RE: A promising presentation12 Apr 2024 08:25
Believe it or not Slacker I don’t think GDR is that far off managing this, or at part to the point where it becomes a much more attractive proposition to offer finance to.
GDR receives £1.2m per year in a R&D tax rebate. Income is currently £250k per year and only going north now there are EU and Middle East sales of AIHL tests. Also some funding from a handful of Grants means GDR could already be well on the way to covering about half its annual costs. If it could find a loan on reasonable terms for about £2m then things start to look interesting.
Everything imo rests on how soon the rest of NHS neonatal units take up AIHL and the NHS starts using the CYP2C19 tests. I actually don’t think it’s that far off. Maybe I’m just getting Misty eyed in my old age, and yes, things are tight just now, but I think GDR is very close to a tipping point where circs look more promising and sentiment from the market will change. Finally.